vs
Side-by-side financial comparison of DYNEX CAPITAL INC (DX) and ORTHOPEDIATRICS CORP (KIDS). Click either name above to swap in a different company.
ORTHOPEDIATRICS CORP is the larger business by last-quarter revenue ($61.6M vs $43.5M, roughly 1.4× DYNEX CAPITAL INC). On growth, DYNEX CAPITAL INC posted the faster year-over-year revenue change (531.3% vs 17.0%). Over the past eight quarters, DYNEX CAPITAL INC's revenue compounded faster (75.8% CAGR vs 17.4%).
Dynex Capital Inc. is a publicly traded real estate investment trust headquartered in the United States. It specializes in investing in and managing a diversified portfolio of mortgage-backed securities, residential and commercial mortgage loans, and other mortgage-related assets. It delivers consistent returns to shareholders via regular dividends and long-term capital growth.
OrthoPediatrics is an American bio-science company engaged in designing, developing, manufacturing, and distributing orthopedic implants and instruments for pediatric issues. It is based in Warsaw, Indiana.
DX vs KIDS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $43.5M | $61.6M |
| Net Profit | — | $-10.1M |
| Gross Margin | — | 73.2% |
| Operating Margin | — | -13.3% |
| Net Margin | — | -16.4% |
| Revenue YoY | 531.3% | 17.0% |
| Net Profit YoY | — | 37.1% |
| EPS (diluted) | $1.59 | $-0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $43.5M | $61.6M | ||
| Q3 25 | $30.6M | $61.3M | ||
| Q2 25 | $23.1M | $61.1M | ||
| Q1 25 | $17.1M | $52.4M | ||
| Q4 24 | — | $52.7M | ||
| Q3 24 | — | $54.6M | ||
| Q2 24 | — | $52.8M | ||
| Q1 24 | $-3.2M | $44.7M |
| Q4 25 | — | $-10.1M | ||
| Q3 25 | $150.4M | $-11.8M | ||
| Q2 25 | $-13.6M | $-7.1M | ||
| Q1 25 | $-3.1M | $-10.7M | ||
| Q4 24 | — | $-16.1M | ||
| Q3 24 | — | $-7.9M | ||
| Q2 24 | — | $-6.0M | ||
| Q1 24 | $40.1M | $-7.8M |
| Q4 25 | — | 73.2% | ||
| Q3 25 | — | 73.9% | ||
| Q2 25 | — | 72.1% | ||
| Q1 25 | — | 73.0% | ||
| Q4 24 | — | 67.5% | ||
| Q3 24 | — | 73.4% | ||
| Q2 24 | — | 77.3% | ||
| Q1 24 | — | 72.0% |
| Q4 25 | — | -13.3% | ||
| Q3 25 | — | -15.4% | ||
| Q2 25 | — | -17.4% | ||
| Q1 25 | — | -21.0% | ||
| Q4 24 | — | -26.7% | ||
| Q3 24 | — | -10.2% | ||
| Q2 24 | — | -10.7% | ||
| Q1 24 | — | -21.8% |
| Q4 25 | — | -16.4% | ||
| Q3 25 | 491.3% | -19.2% | ||
| Q2 25 | -58.8% | -11.6% | ||
| Q1 25 | -18.0% | -20.3% | ||
| Q4 24 | — | -30.5% | ||
| Q3 24 | — | -14.5% | ||
| Q2 24 | — | -11.4% | ||
| Q1 24 | -1256.8% | -17.5% |
| Q4 25 | $1.59 | $-0.43 | ||
| Q3 25 | $1.08 | $-0.50 | ||
| Q2 25 | $-0.14 | $-0.30 | ||
| Q1 25 | $-0.06 | $-0.46 | ||
| Q4 24 | — | $-0.70 | ||
| Q3 24 | — | $-0.34 | ||
| Q2 24 | — | $-0.26 | ||
| Q1 24 | $0.64 | $-0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $531.0M | $60.9M |
| Total DebtLower is stronger | — | $106.0M |
| Stockholders' EquityBook value | $2.5B | $346.6M |
| Total Assets | $17.3B | $508.6M |
| Debt / EquityLower = less leverage | — | 0.31× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $531.0M | $60.9M | ||
| Q3 25 | $491.0M | $57.7M | ||
| Q2 25 | $387.5M | $70.1M | ||
| Q1 25 | $327.4M | $58.8M | ||
| Q4 24 | — | $68.8M | ||
| Q3 24 | — | $76.1M | ||
| Q2 24 | — | $28.9M | ||
| Q1 24 | $295.7M | $47.7M |
| Q4 25 | — | $106.0M | ||
| Q3 25 | — | $105.3M | ||
| Q2 25 | — | $102.7M | ||
| Q1 25 | — | $77.4M | ||
| Q4 24 | — | $77.5M | ||
| Q3 24 | — | $76.9M | ||
| Q2 24 | — | $11.2M | ||
| Q1 24 | — | $11.3M |
| Q4 25 | $2.5B | $346.6M | ||
| Q3 25 | $2.0B | $349.3M | ||
| Q2 25 | $1.6B | $355.5M | ||
| Q1 25 | $1.4B | $347.1M | ||
| Q4 24 | — | $354.6M | ||
| Q3 24 | — | $370.9M | ||
| Q2 24 | — | $371.3M | ||
| Q1 24 | $958.5M | $370.6M |
| Q4 25 | $17.3B | $508.6M | ||
| Q3 25 | $14.2B | $493.5M | ||
| Q2 25 | $11.3B | $503.6M | ||
| Q1 25 | $9.0B | $470.3M | ||
| Q4 24 | — | $473.2M | ||
| Q3 24 | — | $489.3M | ||
| Q2 24 | — | $430.8M | ||
| Q1 24 | $6.3B | $437.2M |
| Q4 25 | — | 0.31× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | 0.22× | ||
| Q4 24 | — | 0.22× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.03× | ||
| Q1 24 | — | 0.03× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $120.8M | $10.3M |
| Free Cash FlowOCF − Capex | — | $9.7M |
| FCF MarginFCF / Revenue | — | 15.8% |
| Capex IntensityCapex / Revenue | — | 1.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-16.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $120.8M | $10.3M | ||
| Q3 25 | $68.3M | $-581.0K | ||
| Q2 25 | $31.9M | $-10.5M | ||
| Q1 25 | $6.4M | $-4.2M | ||
| Q4 24 | — | $-4.0M | ||
| Q3 24 | — | $-10.3M | ||
| Q2 24 | — | $-6.1M | ||
| Q1 24 | $-17.1M | $-6.7M |
| Q4 25 | — | $9.7M | ||
| Q3 25 | — | $-3.4M | ||
| Q2 25 | — | $-13.9M | ||
| Q1 25 | — | $-8.4M | ||
| Q4 24 | — | $-4.2M | ||
| Q3 24 | — | $-11.7M | ||
| Q2 24 | — | $-12.8M | ||
| Q1 24 | — | $-13.2M |
| Q4 25 | — | 15.8% | ||
| Q3 25 | — | -5.6% | ||
| Q2 25 | — | -22.8% | ||
| Q1 25 | — | -16.0% | ||
| Q4 24 | — | -8.1% | ||
| Q3 24 | — | -21.4% | ||
| Q2 24 | — | -24.2% | ||
| Q1 24 | — | -29.4% |
| Q4 25 | — | 1.0% | ||
| Q3 25 | — | 4.6% | ||
| Q2 25 | — | 5.6% | ||
| Q1 25 | — | 8.1% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 2.5% | ||
| Q2 24 | — | 12.7% | ||
| Q1 24 | — | 14.5% |
| Q4 25 | — | — | ||
| Q3 25 | 0.45× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.43× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
